Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Germline variant in SLCO2B1 and response to abiraterone acetate plus prednisone (AA) in new onset metastatic castration-resistant prostate cancer (mCRPC).

Hahn AW, Gill DM, Poole A, Nussenzveig RH, Wilson S, Farnham JM, Stephenson RA, Cannon-Albright LA, Maughan BL, Agarwal N.

Mol Cancer Ther. 2018 Dec 26. pii: molcanther.0739.2018. doi: 10.1158/1535-7163.MCT-18-0739. [Epub ahead of print]

PMID:
30587554
2.

Population genealogy resource shows evidence of familial clustering for Alzheimer disease.

Cannon-Albright LA, Dintelman S, Maness T, Cerny J, Thomas A, Backus S, Farnham JM, Teerlink CC, Contreras J, Kauwe JSK, Meyer LJ.

Neurol Genet. 2018 Aug 1;4(4):e249. doi: 10.1212/NXG.0000000000000249. eCollection 2018 Aug.

3.

Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11q.

Potrony M, Puig-Butille JA, Farnham JM, Giménez-Xavier P, Badenas C, Tell-Martí G, Aguilera P, Carrera C, Malvehy J, Teerlink CC, Puig S.

Eur J Hum Genet. 2018 Aug;26(8):1188-1193. doi: 10.1038/s41431-018-0149-8. Epub 2018 Apr 30.

PMID:
29706638
4.

A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma.

Teerlink CC, Huff C, Stevens J, Yu Y, Holmen SL, Silvis MR, Trombetti K, Zhao H, Grossman D, Farnham JM, Wen J, Facelli JC, Thomas A, Babst M, Florell SR, Meyer L, Zone JJ, Leachman S, Cannon-Albright LA.

J Natl Cancer Inst. 2018 Dec 1;110(12):1380-1385. doi: 10.1093/jnci/djy058.

PMID:
29659923
5.

Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011).

Grossman D, Farnham JM, Hyngstrom J, Klapperich ME, Secrest AM, Empey S, Bowen GM, Wada D, Andtbacka RHI, Grossmann K, Bowles TL, Cannon-Albright LA.

J Am Acad Dermatol. 2018 Aug;79(2):238-244. doi: 10.1016/j.jaad.2018.02.055. Epub 2018 Mar 1.

PMID:
29499295
6.

Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience.

Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW, Murcia JDG, Farnham JM, Damato AR, Allen M, Wang X, Harari O, Fernandez VM, Guerreiro R, Bras J, Hardy J, Munger R, Norton M, Sassi C, Singleton A, Younkin SG, Dickson DW, Golde TE, Price ND, Ertekin-Taner N, Cruchaga C, Goate AM, Corcoran C, Tschanz J, Cannon-Albright LA, Kauwe JSK; Alzheimer’s Disease Neuroimaging Initiative.

Genome Med. 2018 Jan 12;10(1):4. doi: 10.1186/s13073-018-0516-7.

7.

Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience.

Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW, Gonzalez Murcia JD, Farnham JM, Damato AR, Allen M, Wang X, Harari O, Fernandez VM, Guerreiro R, Bras J, Hardy J, Munger R, Norton M, Sassi C, Singleton A, Younkin SG, Dickson DW, Golde TE, Price ND, Ertekin-Taner N, Cruchaga C, Goate AM, Corcoran C, Tschanz J, Cannon-Albright LA, Kauwe JSK; Alzheimer’s Disease Neuroimaging Initiative.

Genome Med. 2017 Nov 29;9(1):100. doi: 10.1186/s13073-017-0486-1. Erratum in: Genome Med. 2018 Jan 12;10 (1):4.

8.

Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer.

Agarwal N, Hahn AW, Gill DM, Farnham JM, Poole AI, Cannon-Albright L.

JAMA Oncol. 2017 Jun 1;3(6):856-857. doi: 10.1001/jamaoncol.2017.0147. No abstract available.

9.

Erratum to "Genome-wide association study for rotator cuff tears identifies two significant single-nucleotide polymorphisms" [J Shoulder Elbow Surg 2016;25:174-179].

Tashjian RZ, Granger EK, Farnham JM, Cannon-Albright LA, Teerlink CC.

J Shoulder Elbow Surg. 2016 Oct;25(10):1731. doi: 10.1016/j.jse.2016.07.001. Epub 2016 Aug 1. No abstract available.

PMID:
27491572
10.

Population-based risks for cancer in patients with ALS.

Gibson SB, Abbott D, Farnham JM, Thai KK, McLean H, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L.

Neurology. 2016 Jul 19;87(3):289-94. doi: 10.1212/WNL.0000000000002757. Epub 2016 May 11.

11.

Inherited Variants in SULT1E1 and Response to Abiraterone Acetate by Men with Metastatic Castration Refractory Prostate Cancer.

Agarwal N, Alex AB, Farnham JM, Patel S, Gill D, Buckley TH, Stephenson RA, Cannon-Albright L.

J Urol. 2016 Oct;196(4):1112-6. doi: 10.1016/j.juro.2016.04.079. Epub 2016 May 3.

PMID:
27150425
12.

Evidence for an Environmental and Inherited Predisposition Contributing to the Risk for Global Tendinopathies or Compression Neuropathies in Patients With Rotator Cuff Tears.

Tashjian RZ, Farnham JM, Granger EK, Teerlink CC, Cannon-Albright LA.

Orthop J Sports Med. 2016 Apr 12;4(4):2325967116642173. doi: 10.1177/2325967116642173. eCollection 2016 Apr.

13.

Genome-wide association study for rotator cuff tears identifies two significant single-nucleotide polymorphisms.

Tashjian RZ, Granger EK, Farnham JM, Cannon-Albright LA, Teerlink CC.

J Shoulder Elbow Surg. 2016 Feb;25(2):174-9. doi: 10.1016/j.jse.2015.07.005. Epub 2015 Sep 5.

PMID:
26350878
14.

Evidence for pelvic organ prolapse predisposition genes on chromosomes 10 and 17.

Allen-Brady K, Cannon-Albright LA, Farnham JM, Norton PA.

Am J Obstet Gynecol. 2015 Jun;212(6):771.e1-7. doi: 10.1016/j.ajog.2014.12.037. Epub 2014 Dec 31.

15.

Prostate cancer risk prediction based on complete prostate cancer family history.

Albright F, Stephenson RA, Agarwal N, Teerlink CC, Lowrance WT, Farnham JM, Albright LA.

Prostate. 2015 Mar 1;75(4):390-8. doi: 10.1002/pros.22925. Epub 2014 Nov 18.

16.

Identification of specific Y chromosomes associated with increased prostate cancer risk.

Cannon-Albright LA, Farnham JM, Bailey M, Albright FS, Teerlink CC, Agarwal N, Stephenson RA, Thomas A.

Prostate. 2014 Jun;74(9):991-8. doi: 10.1002/pros.22821. Epub 2014 May 6.

17.

Pairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees.

Cai Z, Thomas A, Teerlink C, Farnham JM, Cannon-Albright LA, Camp NJ.

BMC Genomics. 2012 Nov 28;13:676. doi: 10.1186/1471-2164-13-676.

18.

Linkage analysis of extended high-risk pedigrees replicates a cutaneous malignant melanoma predisposition locus on chromosome 9q21.

Cannon-Albright LA, Teerlink CC, Farnham JM, Thomas AW, Zone JJ, Leachman SA.

J Invest Dermatol. 2013 Jan;133(1):128-34. doi: 10.1038/jid.2012.271. Epub 2012 Sep 6.

19.

Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.

Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Mæhle L, Møller P, Eeles R, Easton D, Guy M, Edwards S, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Stanford JL, Karyadi DM, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Lange EM, Cooney KA, Tammela TL, Schleutker J, Maier C, Bochum S, Hoegel J, Grönberg H, Wiklund F, Emanuelsson M, Cancel-Tassin G, Valeri A, Cussenot O, Isaacs WB; International Consortium for Prostate Cancer Genetics.

BMC Med Genet. 2012 Jun 19;13:46. doi: 10.1186/1471-2350-13-46.

20.

Identification of six loci associated with pelvic organ prolapse using genome-wide association analysis.

Allen-Brady K, Cannon-Albright L, Farnham JM, Teerlink C, Vierhout ME, van Kempen LC, Kluivers KB, Norton PA.

Obstet Gynecol. 2011 Dec;118(6):1345-53. doi: 10.1097/AOG.0b013e318236f4b5.

21.

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.

Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, Wiklund F, Emanuelsson M, Grönberg H, Wiley KE, Isaacs SD, Walsh PC, Helfand BT, Kan D, Catalona WJ, Stanford JL, FitzGerald LM, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Whittemore AS, Oakley-Girvan I, Hsieh CL, Powell I, Bailey-Wilson JE, Cropp CD, Simpson C, Carpten JD, Seminara D, Zheng SL, Xu J, Giles GG, Severi G, Hopper JL, English DR, Foulkes WD, Maehle L, Moller P, Badzioch MD, Edwards S, Guy M, Eeles R, Easton D, Isaacs WB; International Consortium for Prostate Cancer Genetics.

Prostate. 2012 Mar;72(4):410-26. doi: 10.1002/pros.21443. Epub 2011 Jul 11.

22.

Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.

Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Grönberg H, Wiklund F, Emanuelsson M, Farnham JM, Cannon-Albright LA, Camp NJ; International Consortium for Prostate Cancer Genetics.

Prostate. 2010 May 15;70(7):735-44. doi: 10.1002/pros.21106.

23.

No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees.

Allen-Brady K, Farnham JM, Camp NJ, Karlins E, Ostrander EA, Cannon-Albright LA.

BMC Res Notes. 2009 May 28;2:94. doi: 10.1186/1756-0500-2-94.

24.

Evidence for an inherited predisposition contributing to the risk for rotator cuff disease.

Tashjian RZ, Farnham JM, Albright FS, Teerlink CC, Cannon-Albright LA.

J Bone Joint Surg Am. 2009 May;91(5):1136-42. doi: 10.2106/JBJS.H.00831.

25.

Significant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21.

Allen-Brady K, Norton PA, Farnham JM, Teerlink C, Cannon-Albright LA.

Am J Hum Genet. 2009 May;84(5):678-82. doi: 10.1016/j.ajhg.2009.04.002. Epub 2009 Apr 23.

26.

Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.

Camp NJ, Farnham JM, Wong J, Christensen GB, Thomas A, Cannon-Albright LA.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1290-4. doi: 10.1158/1055-9965.EPI-08-0327. Epub 2009 Mar 31.

27.

Shared genomic segment analysis. Mapping disease predisposition genes in extended pedigrees using SNP genotype assays.

Thomas A, Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA.

Ann Hum Genet. 2008 Mar;72(Pt 2):279-87. Epub 2007 Dec 18.

28.

Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.

Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA.

Prostate. 2007 Sep 15;67(13):1456-64.

PMID:
17654497
29.

Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics.

Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Grönberg H, Wiklund F, Emanuelsson M, Isaacs WB; International Consortium for Prostate Cancer Genetics.

Hum Mol Genet. 2007 Jun 1;16(11):1271-8. Epub 2007 May 3.

30.

Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees.

Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA.

Prostate. 2007 May 1;67(6):605-13.

PMID:
17299800
31.
32.

Identification and study of Utah pseudo-isolate populations-prospects for gene identification.

Cannon-Albright LA, Farnham JM, Thomas A, Camp NJ.

Am J Med Genet A. 2005 Sep 1;137A(3):269-75.

PMID:
16096997
33.

Genomic search for prostate cancer predisposition loci in Utah pedigrees.

Camp NJ, Farnham JM, Cannon Albright LA.

Prostate. 2005 Dec 1;65(4):365-74.

PMID:
16037989
34.

Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer.

Camp NJ, Swensen J, Horne BD, Farnham JM, Thomas A, Cannon-Albright LA, Tavtigian SV.

Genet Epidemiol. 2005 Apr;28(3):232-43.

PMID:
15593091
35.

Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees.

Farnham JM, Camp NJ, Swensen J, Tavtigian SV, Albright LA.

Hum Genet. 2005 Feb;116(3):179-85. Epub 2004 Dec 8.

PMID:
15592687
36.

A cautionary note on the appropriateness of using a linkage resource for an association study.

Allen-Brady K, Farnham JM, Weiler J, Camp NJ.

BMC Genet. 2003 Dec 31;4 Suppl 1:S89.

37.

Confirmation of chromosome 7q11 locus for predisposition to intracranial aneurysm.

Farnham JM, Camp NJ, Neuhausen SL, Tsuruda J, Parker D, MacDonald J, Cannon-Albright LA.

Hum Genet. 2004 Feb;114(3):250-5. Epub 2003 Nov 6.

PMID:
14605871
38.

A genealogical assessment of heritable predisposition to aneurysms.

Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG.

J Neurosurg. 2003 Oct;99(4):637-43.

PMID:
14567597
39.

Correcting for multiple analyses in genomewide linkage studies.

Camp NJ, Farnham JM.

Ann Hum Genet. 2001 Nov;65(Pt 6):577-82.

40.

Allelic association in large pedigrees.

Gutin A, Abkevich V, Camp NJ, Farnham JM, Cannon-Albright L, Thomas A.

Genet Epidemiol. 2001;21 Suppl 1:S571-5.

PMID:
11793740
41.

A robust multipoint linkage statistic (tlod) for mapping complex trait loci.

Abkevich V, Camp NJ, Gutin A, Farnham JM, Cannon-Albright L, Thomas A.

Genet Epidemiol. 2001;21 Suppl 1:S492-7.

PMID:
11793725
42.

A new nonparametric linkage statistic for mapping both qualitative and quantitative trait loci.

Camp NJ, Gutin A, Abkevich V, Farnham JM, Cannon-Albright L, Thomas A.

Genet Epidemiol. 2001;21 Suppl 1:S461-6.

PMID:
11793719
43.

A simple diagnostic index for asthma.

Bansal A, Farnham JM, Crapo RO, Hughes DC, Jensen RL, Cannon-Albright LA.

Clin Exp Allergy. 2001 May;31(5):756-60.

PMID:
11422135
44.

Impact of correlated factors on bone density in individuals with a family history of osteoporosis.

Bansal A, Hughes DC, Farnham JM, Bagi CM, O'Neil G, Rowe K, Shakib JH, Wood GC, Wyckoff JA, Cannon-Albright LA.

J Clin Densitom. 2000 Winter;3(4):333-8.

PMID:
11175913
45.

A candidate prostate cancer susceptibility gene at chromosome 17p.

Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA.

Nat Genet. 2001 Feb;27(2):172-80.

PMID:
11175785
46.

Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees.

Neuhausen SL, Farnham JM, Kort E, Tavtigian SV, Skolnick MH, Cannon-Albright LA.

Hum Mol Genet. 1999 Dec;8(13):2437-42.

PMID:
10556291
47.

Novel popout with nonsense strings: effects of predictability of string length and spatial location.

Hawley KJ, Johnston WA, Farnham JM.

Percept Psychophys. 1994 Mar;55(3):261-8.

PMID:
8036107
48.

Can standard measures identify subclinical markers of autism?

Ozonoff S, Rogers SJ, Farnham JM, Pennington BF.

J Autism Dev Disord. 1993 Sep;23(3):429-41.

PMID:
8226580

Supplemental Content

Loading ...
Support Center